[Review of literature and experimental contribution on KO 592, a drug with beta-adrenolytic activity. I].
D000433:1-Propanol / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D000605:Amino Alcohols / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002415:Cats; D003408:Cresols / Q000627:therapeutic use; D004562:Electrocardiography; D005069:Evaluation Studies as Topic; D005227:Fatty Acids / Q000097:blood; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D006980:Hyperthyroidism / Q000188:drug therapy; D009132:Muscles / Q000187:drug effects; D010673:Pheochromocytoma / Q000188:drug therapy; D011437:Propylamines / Q000627:therapeutic use; D051381:Rats; D013270:Stomach / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology*; D013771:Tetralogy of Fallot / Q000188:drug therapy; D014132:Trachea / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D003408:Cresols; D005227:Fatty Acids; D011437:Propylamines; D013565:Sympatholytics; D000433:1-Propanol
Rassegna bibliografica e contributo sperimentale sul KO 592 farmaco ad attività beta-adrenolitica.